A detailed history of National Asset Management, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, National Asset Management, Inc. holds 1,265 shares of MEDP stock, worth $511,591. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,265
Previous 1,254 0.88%
Holding current value
$511,591
Previous $384,000 33.07%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 16, 2024

BUY
$284.87 - $413.31 $3,133 - $4,546
11 Added 0.88%
1,265 $511,000
Q4 2023

Mar 15, 2024

SELL
$227.52 - $312.68 $2,502 - $3,439
-11 Reduced 0.87%
1,254 $384,000
Q3 2023

Dec 01, 2023

BUY
$233.98 - $281.67 $2,339 - $2,816
10 Added 0.8%
1,265 $306,000
Q2 2023

Jul 27, 2023

SELL
$187.26 - $240.17 $293,998 - $377,066
-1,570 Reduced 55.58%
1,255 $301,000
Q1 2023

May 17, 2023

BUY
$174.31 - $239.52 $131,255 - $180,358
753 Added 36.34%
2,825 $531,000
Q4 2022

Feb 21, 2023

BUY
$153.06 - $226.57 $317,140 - $469,453
2,072 New
2,072 $440,000
Q1 2022

May 02, 2022

SELL
$138.87 - $214.31 $294,959 - $455,194
-2,124 Closed
0 $0
Q4 2021

Jan 28, 2022

BUY
$182.74 - $227.9 $1,279 - $1,595
7 Added 0.33%
2,124 $463,000
Q3 2021

Nov 16, 2021

SELL
$170.18 - $198.21 $9,530 - $11,099
-56 Reduced 2.58%
2,117 $401,000
Q2 2021

Aug 10, 2021

BUY
$158.62 - $194.3 $8,565 - $10,492
54 Added 2.55%
2,173 $384,000
Q1 2021

May 13, 2021

SELL
$132.02 - $168.26 $8,317 - $10,600
-63 Reduced 2.89%
2,119 $348,000
Q4 2020

Feb 04, 2021

SELL
$109.38 - $149.19 $11,156 - $15,217
-102 Reduced 4.47%
2,182 $305,000
Q3 2020

Nov 09, 2020

BUY
$92.95 - $130.61 $212,297 - $298,313
2,284 New
2,284 $254,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $12.6B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.